臨床試験を検索:エクセナチド持続放出2mg(ビデュレオン)
合計1051件
-
Astellas Pharma Inc完了
-
Ironshore Pharmaceuticals and Development, Inc完了
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Center for...完了
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完了
-
Luye Pharma Group Ltd.完了
-
Alkermes, Inc.終了しました
-
Merck Sharp & Dohme LLC終了しました
-
Johnson & Johnson Pharmaceutical Research & Development...Grünenthal GmbH完了
-
University of MinnesotaAstraZeneca; University of Iowa; Mclean Hospital完了
-
Woman'sAstraZeneca完了
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...完了
-
Applied Science & Performance Institute募集
-
The Methodist Hospital Research InstituteVeloxis Pharmaceuticals引きこもった腎移植の急性拒絶反応 | 腎疾患、末期 | ドナー特異的抗体
-
Collaborative Care Initiative, LLCDauten Family Center for Bipolar Treatment Innovation, Massachusetts Gen Hospitalわからない
-
Abbott完了慢性気管支炎の急性細菌性増悪(ABECB)。アメリカ, カナダ, プエルトリコ
-
Mylan Pharmaceuticals Inc完了
-
Yonsei University完了
-
Laboratorios Silanes S.A. de C.V.Instituto Mexicano del Seguro Social完了
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完了
-
Columbia UniversityVeloxis Pharmaceuticals積極的、募集していない
-
Roy D. Bloom, MDVeloxis Pharmaceuticals募集